Provectus Biopharmaceuticals PVCT
OTC PVCT
$0.05 +0.00 (+0.00%)
At close: Oct 20, 2026 · 4:00 PM EDT

Provectus Biopharmaceuticals (PVCT) Return on Equity [ROE] (2011 - 2017)

Updated

Provectus Biopharmaceuticals' Return on Equity [ROE] came in at -1600.17% for Q1 2017, down 1413.05 percentage points from -187.11% a year earlier and down 1041.79 percentage points from the prior quarter.

Analysis

Provectus Biopharmaceuticals (PVCT) Return on Equity [ROE] (2011 - 2017) Analysis & Trends

For FY2016, Provectus Biopharmaceuticals' Return on Equity [ROE] was -247.75%, down 128.98 percentage points from FY2015.

  • Return on Equity [ROE] carries a five-year change of -40.80 percentage points (FY2011 to FY2016).
  • Going back by year, Return on Equity [ROE] was -118.77% in FY2015 (-39.40 pp), -79.37% in FY2014 (+157.00 pp), -236.37% in FY2013 (-37.44 pp) and -198.93% in FY2012 (+8.02 pp).
  • The Q1 2017 figure represents the lowest quarterly Return on Equity [ROE] in data going back to Q3 2011.
  • Year-over-year, Return on Equity [ROE] has declined for six consecutive quarters, with an average year-over-year change of -316.61 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Equity [ROE] over five years came in Q3 2013 (a gain of 232.62 percentage points), and the weakest in Q1 2017 (a drop of 1413.05 percentage points).
  • Business Quant data shows PVCT's Return on Equity [ROE] at -558.38% (Q4 2016), -401.23% (Q3 2016) and -248.58% (Q2 2016) in the three quarters before Q1 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,149.64 Bn 1,118.23 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 626.55 Bn 545.08 Bn 17.26 Bn 25.32%
3 AbbVie 498.79 Bn 471.91 Bn 12.70 Bn -
4 Merck 371.66 Bn 326.04 Bn 12.21 Bn 7.21%
5 Novartis Ag 299.96 Bn 263.95 Bn 11.24 Bn 31.52%
6 Astrazeneca 263.22 Bn 236.91 Bn 12.86 Bn 21.39%
7 Amgen 237.03 Bn 192.43 Bn 7.24 Bn 83.75%
8 Gilead Sciences 191.20 Bn 165.40 Bn 6.22 Bn -18.38%
9 Pfizer 170.83 Bn 117.47 Bn 10.94 Bn 4.97%
10 Provectus Biopharmaceuticals 21.01 Mn 19.10 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2017 -1,600.17%
Dec 31, 2016 -558.38%
Sep 30, 2016 -401.23%
Jun 30, 2016 -248.58%
Mar 31, 2016 -187.11%
Dec 31, 2015 -120.69%
Sep 30, 2015 -55.69%
Jun 30, 2015 -51.20%
Mar 31, 2015 -54.88%
Dec 31, 2014 -56.46%
Sep 30, 2014 -76.96%
Jun 30, 2014 -87.14%
Mar 31, 2014 -133.91%
Dec 31, 2013 -169.71%
Sep 30, 2013 -165.04%
Jun 30, 2013 -209.77%
Mar 31, 2013 -271.63%
Dec 31, 2012 -366.77%
Sep 30, 2012 -397.67%
Jun 30, 2012 -368.37%
API Access

Provectus Biopharmaceuticals Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PVCT&period=max&api_key=YOUR_API_KEY